Production of [211At]-Astatinated Radiopharmaceuticals and Applications in Targeted α-Particle Thera...
Production of [211At]-Astatinated Radiopharmaceuticals and Applications in Targeted α-Particle Therapy
About this item
Full title
Author / Creator
Publisher
New Rochelle, NY: Liebert
Journal title
Language
English
Formats
Publication information
Publisher
New Rochelle, NY: Liebert
Subjects
More information
Scope and Contents
Contents
(211)At is a promising radionuclide for α-particle therapy of cancers. Its physical characteristics make this radionuclide particularly interesting to consider when bound to cancer-targeting biomolecules for the treatment of microscopic tumors. (211)At is produced by cyclotron irradiation of (209)Bi with α-particles accelerated at ~28 MeV and can b...
Alternative Titles
Full title
Production of [211At]-Astatinated Radiopharmaceuticals and Applications in Targeted α-Particle Therapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3545490
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3545490
Other Identifiers
ISSN
1084-9785
E-ISSN
1557-8852
DOI
10.1089/cbr.2012.1292
